Inventor · disambiguated record
Jodi T. Williams
Also filed as: WILLIAMS JODI · WILLIAMS JODI T
17 granted patents·5 pending applications·58 citations·filing 2009–2023
92Inventor score
Files withIDORSIA PHARMACEUTICALS LTD10AISSAOUI HAMED5ACTELION PHARMACEUTICALS LTD3BOLLI MARTIN2BOSS CHRISTOPH2
Top patents by PatentIndex Score
22 records- 0187US9732075B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2013·Granted Aug 15, 2017·8 cites·12 claims
- 0284US10329287B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Jun 25, 2019·3 cites·12 claims
- 0384US9150566B22-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonistsBOLLI MARTIN·Filed 2012·Granted Oct 6, 2015·7 cites·27 claims
- 0483US10023560B2Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonistIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Jul 17, 2018·3 cites·13 claims
- 0583US9211279B2Proline sulfonamide derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Dec 15, 2015·3 cites·30 claims
- 0682US12344597B2Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosisIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Jul 1, 2025·2 cites·21 claims
- 0782US9493446B2Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Nov 15, 2016·6 cites·21 claims
- 0881US9790208B2Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonistIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Oct 17, 2017·4 cites·6 claims
- 0981US8895606B2Proline sulfonamide derivatives as orexin receptor antagonistsBOSS CHRISTOPH·Filed 2011·Granted Nov 25, 2014·5 cites·9 claims
- 1080US9000029B2Proline sulfonamide derivatives as orexin receptor antagonistsBOSS CHRISTOPH·Filed 2014·Granted Apr 7, 2015·4 cites·13 claims
- 1178US9914720B2Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonistsIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 13, 2018·3 cites·12 claims
- 1278US9914721B2Use of benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 13, 2018·4 cites·14 claims
- 1375US9242970B2Lactam derivatives useful as orexin receptor antagonistsAISSAOUI HAMED·Filed 2011·Granted Jan 26, 2016·3 cites·12 claims
- 1471US11040966B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Jun 22, 2021·0 cites·29 claims
- 1568US9403813B2Azetidine amide derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Aug 2, 2016·1 cites·12 claims
- 1668US9303023B2Pyrazole and imidazole derivatives useful as orexin antagonistsBOLLI MARTIN·Filed 2012·Granted Apr 5, 2016·1 cites·12 claims
- 1767US8329706B2Oxazolidinone derivativesAISSAOUI HAMED·Filed 2010·Granted Dec 11, 2012·1 cites·15 claims
- 1865US2025268979A1Combination of macrocyclic cftr modulators with cftr correctors and / or cftr potentiatorsIDORSIA PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1952US2011086889A1Tetrazole compounds as orexin receptor antagonistsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 2052US2011212968A1Phenethylamide derivatives and their heterocyclic analoguesAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 2152US2024208992A1Macrocycles as cftr modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2236US2012088759A1Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonistsAISSAOUI HAMED·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jodi T. Williams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →